2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Á÷¾÷ޱ¸ ½ºÅ丮ºÏ ¡®¹«ÇÑÀÇ °è´Ü ¹Ì·¡¼Ò³â ¹Ö¸ð 1¡¯ (2024-07-20)
2024 Æø½º¹Ù°Õ ¼­ºñ½º °Ü¿ï Ä·ÆäÀÎ (2024-12-04)
LG CNS, ¹Ì±¹¼­ ½º¸¶Æ®ºôµù DX »ç¾÷ º»°ÝÈ­ (2024-12-04)
¹®È­Ã¼À°°ü±¤ºÎ ¡®¾ç¼ºÆòµî ½ºÅ丮 °ø¸ðÀü¡¯ (2024-08-21)
Galderma Premieres Positive Interim Results Demonstrating th... (2025-01-22)
ÀÌâȣ Ä®·³ - ½ºÇÇÄ¡´Â Áø½ÇÀ» ¸»ÇØ¾ß ÇÑ´Ù (2014-01-20)
±â¾Æ, PBV »ç¾÷ º»°ÝÈ­ Âø¼ö (2023-07-20)
´õ¸¶ºñ, ½Åü ºÎÀ§º° ¶¡ ³¿»õ Àâ´Â ÄÉ¾î ¼Ö·ç¼Ç Á¦°ø (2024-08-09)
¸í¼¼ºó ¡°ÇÁ¸°¼¼ºó ¾Æ´Ñ ¡®ºÒ·®¼¼ºó¡¯ º¸¿©µå·È´Âµ¥¡± (2024-12-02)
Keturah Announces Campaign for Its Developments, Introduces ... (2024-12-07)
±â¾Æ, 19°³ ºÐ¾ß¼­ ÇϹݱ⠴ëÁ¹ ½ÅÀÔ»ç¿ø ä¿ë (2024-08-29)
¿¡±×µå¶ø, Çʸ®ÇÉ¿¡ ±Û·Î¹ú ¸ÅÀå ¿ÀÇ °èȹ (2023-12-22)
ºÎ»ê¡¤°æ³² ÁÖ·ù¹®È­Æä½ºÆ¼¹ú ¡®ºÎ»ê±¹Á¦ÁÖ·ù¹Ú¶÷ȸ¡¯ °³¸· (2024-08-17)
¸ÇÀκí·Ï, ±âº¸º¥Ã³Ä·ÇÁ ¿ì¼ö»ó À̾î Áß±âºÎ ¿ì¼ö±â¾÷ ¼±Á¤ (2024-08-17)
°æ±âµµ¡¤Çϳ²µµ½Ã°ø»ç¡¤Á¤º¸Åë½Å»ê¾÷ÁøÈï¿ø¡¤°­³²´ë ä¿ë (2024-08-17)
Alsym Energy Announces $78M Funding Round Led by Tata Limite... (2024-04-05)
¡®µ¶¹ÚÁ ÁØÈ£ ³î¸®±â·Î ´ëȯÀå ÄɹÌ... ±èÁö¹Î ÀÏÀÏ ³²Ä£Àº ... (2024-11-30)
KnowBe4 Launches Threat Labs Research and Analysis Initiativ... (2025-02-16)
À̼ø½ÅÀÇ °¨µ¿¸®´õ½Ê (2014-09-07)
¾Æµð´Ù½º, ¾Ú¹ö¼­´õ ¼ÕÈï¹Î°ú ÇÔ²² ¡®³Î ¹Ï¾î¡¯ Ä·ÆäÀÎ (2024-06-15)
°¡¿¬¸®, ¡®ÇÏÀÌ ¼­¸Ó Ȧ¸®µ¥ÀÌ 24 Ä÷º¼Ç¡¯ Ãâ½Ã (2024-07-24)
»ï¼ºÀüÀÚ, AI ±â´É °­È­µÈ 2024³âÇü ÃÊ´ëÇü TV ÆÇ¸Å È£Á¶ (2024-07-07)
´ëÇÑÀü¼±, ½Å¿ëµî±Þ A·Î »óÇâ... ¾ÈÁ¤Àû »ç¾÷ ¹× ¿µ¾÷¼öÀͼº (2024-08-15)
Gain Theory and The Association of National Advertisers (ANA... (2024-03-15)
¹Ú½ÅÈ£ º¯È£»ç Ä®·³ - °í¾× Àü¼¼¿¡ Àç»ê¼¼ ºÎ°úÇØ¾ß (2013-09-12)
       [ÀÌÀü][1]....[525][526][527][528][529][530][531][532][533]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..